The Market Reports

Synopsis
The global market for Transcriptome Sequencing was estimated to be worth US$ 2571 million in 2024 and is forecast to a readjusted size of US$ 6073 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Transcriptome sequencing employs high-throughput sequencing technologies to get access to almost all transcripts of specific tissues or cells in a certain state by comprehensive and rapid cDNA sequencing, becoming the basis as well as the starting point for the research of gene expression. The main objectives of transcriptome research include the classification of all transcriptional products, the determination of the transcription structure of genes (such as starting sites, 5′ and 3′ terminals, splicing patterns, and post-transcriptional modifications), and the changes in the expression levels of individual transcripts during development. This technology has been widely used in biological research, medical and clinical research, and drug development.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The cost of RNA-Seq has decreased significantly over the past decade, making it more accessible to researchers and clinicians. This cost reduction is driven by advancements in sequencing technologies and economies of scale. Transcriptome sequencing is playing a critical role in identifying patient-specific biomarkers and therapeutic targets. The growing focus on precision medicine is driving adoption in oncology, rare diseases, and pharmacogenomics. Increased funding for genomics and transcriptomics research from governments, non-profits, and private investors is supporting market growth. Initiatives like the Cancer Genome Atlas (TCGA) and Human Cell Atlas (HCA) are driving large-scale transcriptome studies.
This report aims to provide a comprehensive presentation of the global market for Transcriptome Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transcriptome Sequencing by region & country, by Type, and by Application.
The Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptome Sequencing.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Eurofins Scientific
Roche
Bio-Rad
Agilent Technologies
LabCorp
QIAGEN
Pacific Biosciences
Azenta
BGI Genomics
Novogene
Macrogen
Shanghai ZJ Bio-Tech
Tsingke Biotechnology
Segment by Type
Coding RNA
Noncoding RNA
Segment by Application
Biomedical Field
Non-medical Field
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transcriptome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Transcriptome Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Transcriptome Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index